￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of the anti-cancer mechanism of Doxorubicin and its application value in tumor treatment

2026-02-01 22:25:32

Check Details
Can Platinib (Pujihua) be used in conjunction with the immunotherapy regimen?

2026-02-01 22:25:32

Check Details
Research progress on the possibility of capmatinib (Touradida) treating other types of cancer

2026-02-01 22:25:32

Check Details
Analysis of the differences in treatment strategies between sotoracib (AMG 510) and osimertinib

2026-02-01 22:25:32

Check Details
Study results on whether adagrasib (Krazati) needs to be combined with other drugs

2026-02-01 22:25:32

Check Details
Detailed description of Pimitespib’s launch time and drug purchasing channels in China

2026-02-01 22:25:32

Check Details
The latest price and medical insurance reference information of Afatinib in 2025

2026-02-01 22:25:32

Check Details
Clinical efficacy and evaluation of the treatment of insomnia with DaliRasheng (Keweike)

2026-02-01 22:25:32

Check Details
Instructions on whether the drug can be stopped at will after long-term use of Lynparza

2026-02-01 22:25:32

Check Details
Detailed explanation of whether Venetoclax has been included in medical insurance and reimbursement policy

2026-02-01 22:25:32

Check Details
Asciminib China listing status and official approval information

2026-02-01 22:25:32

Check Details
Will ritexitinib (Lefenox) affect menstruation and precautions for female medication?

2026-02-01 22:25:32

Check Details
Category
相关知识